Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
François Lemonnier(Inserm), Jehan Dupuis(Hôpitaux Universitaires Henri-Mondor), Pierre Sujobert(Université Claude Bernard Lyon 1), Olivier Tournillhac, Morgane Cheminant(Délégation Paris 5), Clémentine Sarkozy(Université Claude Bernard Lyon 1), Laura Pelletier(Inserm), Ambroise Marçais(Délégation Paris 5), Cyrielle Robe(Inserm), Virginie Fataccioli(Inserm), Corinne Haïoun(Inserm), Olivier Hermine(Délégation Paris 5), Philippe Gaulard(Inserm), Richard Delarue(Délégation Paris 5)
Cited by 178Open Access
Abstract
TO THE EDITOR: Peripheral T-cell lymphomas (PTCLs) are heterogeneous diseases resulting from the malignant transformation of mature T or natural killer cells. Their epidemiology varies widely, but PTCLs that derive from T follicular helper (TFH) cells, which include angioimmunoblastic T-cell
Related Papers
No related papers found
Powered by citation graph analysis